We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Regeneron and Bluebird Bio have announced that they will collaboration to apply their respective technology platforms to the discovery, development and commercialisation of novel immune cell therapies for cancer.